Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Malignant Neoplasms of Independent (Primary) Multiple Sites: early-phase trial registry
1 of 5 indexed Malignant Neoplasms of Independent (Primary) Multiple Sites trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #3,391 of 28,707 conditions by registered trial count.
5 US clinical trials · 1 currently recruiting · #3,391 of 28,707 conditions by registered trial count
Malignant Neoplasms of Independent (Primary) Multiple Sites: 5 US clinical trials tracked, 1 recruiting.
Malignant Neoplasms of Independent (Primary) Multiple Sites is the subject of 5 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is M.D. Anderson Cancer Center, running 5 of these trials.
Enrollment posture brief
Registry condition malignant-neoplasms-of-independent-primary-multiple-sites
OPEN 1 | RECR 20% | LATE 0 | EARLY 2 | RANK #3391 | SPON 5
Volume-matched condition peers
Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive (20% recruiting · 10 trials)
Malignant Neoplasms of Independent (Primary) Multiple Sites lists 1 open slots (20% of 5 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Malignant Neoplasms of Independent (Primary) Multiple Sites on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Malignant Neoplasms of Independent (Primary) Multiple Sites is recruiting below its size-band peers.
1 of 5 indexed trials (20%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Malignant Neoplasms of Independent (Primary) Multiple Sites research.
M.D. Anderson Cancer Center accounts for 5 of 5 trials (100%). 1 distinct sponsors appear on at least one study for this condition label.
-
Typical Malignant Neoplasms of Independent (Primary) Multiple Sites enrolment sits around 101 participants.
Median target enrolment is 101 among the 5 trials that report a genuine target (sentinel values excluded). 2 of those (40%) plan for fewer than 100 participants.
-
Malignant Neoplasms of Independent (Primary) Multiple Sites research is mostly interventional.
4 interventional and 1 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
5 total, page 1 of 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
M.D. Anderson Cancer Center
NCT03093909
Expectations Regarding Mobility and Self-Care
M.D. Anderson Cancer Center
NCT02911064
Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT
M.D. Anderson Cancer Center
NCT03435952
Effect of Physician Attire on Patients' Preference of Physician
M.D. Anderson Cancer Center
NCT03168763
Communication Strategies to Introduce Psychology Services
M.D. Anderson Cancer Center
NCT03035448
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Malignant Neoplasms of Independent (Primary) Multiple Sites records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Malignant Neoplasms of Independent (Primary) Multiple Sites trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Malignant Neoplasms of Independent (Primary) Multiple Sites page
5 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 1 Malignant Neoplasms of Independent (Primary) Multiple Sites trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- M.D. Anderson Cancer Center sponsors the most Malignant Neoplasms of Independent (Primary) Multiple Sites trials on record, review their full trial history before evaluating a specific study. See M.D. Anderson Cancer Center's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Malignant Neoplasms of Independent (Primary) Multiple Sites condition card totals 5 registered trials; most-linked intervention Questionnaires; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.